NYSE:CAH

Cardinal Health stock today: CAH slips in early trade after forecast hike

Cardinal Health shares fell 0.2% to $226.66 Friday morning, despite raising its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share after beating quarterly estimates. Second-quarter revenue rose 19% to $65.6 billion, with adjusted EPS at $2.63. CEO Jason Hollar cited strong specialty medicine demand but downplayed obesity drugs’ profit impact. Cencora rose 0.9%, McKesson slipped 0.4%.

6 February 2026

Earnings Reports·NYSE:CAH·Stock Market

McKesson stock steadies after post-earnings surge as Wall Street rechecks the playbook

McKesson shares slipped 0.1% to $956.71 in early New York trading Friday after a 16.5% surge the previous session. The company raised its fiscal 2026 adjusted earnings guidance to $38.80-$39.20 per share and confirmed plans to spin off its medical-surgical unit with an IPO targeted for late 2027. Fiscal Q3 revenue rose 11% to $106.2 billion.

6 February 2026

Earnings·NYSE:CAH·NYSE:MCK

Cardinal Health stock jumps 9% after earnings beat — what CAH investors watch next

Cardinal Health shares jumped 9% to $226.05 Thursday after the company raised its fiscal 2026 adjusted earnings forecast to $10.15-$10.35 per share. Quarterly revenue rose 19% and adjusted profit beat estimates, driven by strong specialty drug demand. CEO Jason Hollar cited double-digit profit growth across all segments. Specialty medicines, including GLP-1 drugs, contributed significantly to revenue gains.

5 February 2026

Earnings Reports·NYSE:CAH·NYSE:CENC·NYSE:MCK·Stock Market

Cardinal Health (CAH) Stock Pulls Back From Record Highs: Latest News, Forecasts and Investment Outlook as of December 3, 2025

Cardinal Health shares fell 2.64% to $199.71 on December 3, 2025, marking a fifth straight daily loss and leaving the stock 7% below its November 52-week high. The drop came despite gains in major indices. Recent filings show OMERS and Quantbot Technologies increased their stakes in the company. Cardinal Health has returned 74% over the past year.

4 December 2025

NYSE:CAH·Stock Market

Cardinal Health (NYSE: CAH) Stock Soars to Record High on Blowout Earnings and Raised Outlook

Cardinal Health shares jumped 13% to record highs near $185 after fiscal Q1 2026 results beat estimates, with adjusted EPS at $2.55 and revenue at $64.0 billion. The company raised its full-year outlook and announced a $375 million buyback. All five segments grew profits, marking an eighth straight earnings beat. Cardinal plans to close the Solaris Health acquisition by early November.

30 October 2025

Earnings Reports·NYSE:CAH·Stock Market

Xanadu Quantum Technologies to List on Nasdaq and TSX After Shareholder Approval
March 20, 2026, 12:11 AM EDT. Xanadu Quantum Technologies is set to become the first publicly listed photonic quantum technology company. Following shareholder approval of the merger with Crane Harbor Acquisition Corp. (Nasdaq: CHAC), the new entity, Xanadu Quantum Technologies Limited, will begin trading on Nasdaq and the Toronto Stock Exchange under ticker "XNDU" on March 27, 2026. The merger will provide approximately $302 million in gross proceeds to support Xanadu's development of light-based quantum computing technology, which operates at room temperature and avoids costly cooling systems. This capital complements a potential CAD 390 million investment from Canadian and Ontario governments, backing the company's efforts to scale its hardware, software, and cloud-based quantum platforms.